Leukemia Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL) - 2020
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-08-11
Aug 11, 2021
A
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +175 more
2021-08-16
Aug 16, 2021
M
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
  • Central Nervous System Lymphoma
  • +5 more
  • Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-08-12
Aug 12, 2021
M
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-08-06
Aug 6, 2021
D
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
Recruiting
  • Leukemia
  • Boston, Massachusetts
  • +1 more
2021-08-02
Aug 2, 2021
M
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-07-30
Jul 30, 2021
M
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue - 2020
Completed
Has Results
  • Leukemia
  • CLL
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-06-30
Jun 30, 2021
D
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
2021-06-16
Jun 16, 2021
S
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia - 2002
Completed
  • Leukemia
  • Duarte, California
  • +19 more
2021-06-07
Jun 7, 2021
M
MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy - 2019
Terminated
Has Results
  • Leukemia
  • MEK 162
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-03-25
Mar 25, 2021
C
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia - 2020
Completed
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +197 more
2021-03-22
Mar 22, 2021
M
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood - 2021
Completed
  • Leukemia
  • Lymphoma
  • HSCT
  • DLI
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-03-09
Mar 9, 2021
M
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML) - 2014
Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-21
Jan 21, 2021
M
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome - 2014
Completed
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-12
Jan 12, 2021
M
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
Recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-01-13
Jan 13, 2021
M
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention - 2020
Completed
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-06
Jan 6, 2021
N
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies - 2009
Completed
Has Results
  • Lymphoma
  • +2 more
  • Augusta, Georgia
  • +6 more
2020-12-16
Dec 16, 2020
M
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
Active, not recruiting
  • Leukemia
  • +2 more
  • Cognitive Training Program
  • Control Group
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-12-29
Dec 29, 2020
M
A Study of Actonel for the Prevention of Bone Loss - 2014
Completed
Has Results
  • Leukemia
  • Lymphoma
  • Actonel (Risedronate)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-12-02
Dec 2, 2020
M
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk - 2020
Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-12-01
Dec 1, 2020
M
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia - 2013
Completed
Has Results
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-12-01
Dec 1, 2020
M
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia - 2020
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-11-12
Nov 12, 2020
M
An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) - 2019
Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-09-29
Sep 29, 2020
M
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin - 2012
Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
M
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-10-02
Oct 2, 2020